Position in TLRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$48,997
-$117,768 QoQ
Shares Held
7,573
-59.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 89%
Shared 10%
None 1%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $672,208,369 across 64 Drug Manufacturers - Specialty & Generic names. TLRY ranks #31 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,974,284 | $233,380,104 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
9,984,082 | $138,279,533 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
11,363,498 | $61,362,887 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
332,300 | $43,777,199 | |
| 5 | VTRS |
Viatris Inc
|
2,907,645 | $39,282,278 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
59,152 | $35,075,949 | |
| 7 | HLN |
Haleon plc
|
3,063,916 | $30,669,795 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
963,824 | $29,030,375 |
All Filings in TLRY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,997 | 7,573 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $166,765 | 18,468 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||